GMP News, GMP guidelines, GMP Violations, GMP warnings A Public Health Global News Portal

Welcome to gmpviolations.com FDA, WHO, EU, TGA, CDSCO guidelines...and GMP Violations news/warning letters..

150000+ Industry Leaders already read it everyday

Monday, March 20, 2017

What is the Role of Quality Unit? What ICH guideline says?

Easy Learning ICH Q7-Part 3 by Anshu Yadav

Quality Unit-Role and Function

An independent Quality unit is an essential requirement of the ICH guidelines. Thus it is required to know the function of a Quality unit [Section 2.2 of ICH].

     
Handle
        All quality related matters.
Review
        Validation protocols & report, Quality related document, Batch    
        Production and laboratory control records before release of API.
Release
         APIs, Intermediates, Raw material, Packaging material and labeling       
         material.
Reject
         APIs, Intermediates, Raw material, Packaging material and labeling   
         material.
Approve
         Specification, Master production Instruction, All procedures
         impacting quality of Intermediate/API, Validation protocols &
         reports and approving intermediate and contract manufacturers.
Perform
         Product Quality Review
Ensure
        Critical deviation and quality related complaints are investigated &   
         resolved, Internal audit are performed
         Effective systems are used for maintaining and calibrating critical  
         equipment.
        Materials are appropriately tested and results are reported.
         Stability data is there to support retest or expiry dates and storage  
         condition

The Quality control is responsible for the laboratory control function [Section 11 of ICH].To conduct all the above activity, the quality unit should have an adequate laboratory facilities.




Laboratory control [Section 11 of ICH]  
General Control
·        Documented procedure for all the relevant activities of the Quality Unit [Section 6.6]
·        Scientifically sound test procedure, specification and sampling plans.
·        Specifications which should include
o Appropriate specification in accordance with accepted standard and consistent with the manufacturing process
o Control of Impurity
o Microbiological purity (if applicable) –[Action limit for total microbial counts and objectionable organism should be established]
o Endotoxin(if applicable)
·        The activity should be recorded at the time of performance.

·        All the function mentioned in Section 2.2 of ICH should be followed.


Testing of Intermediate and APIs

Laboratory test are conducted to determine the requirement of specifications are fulfilled or not. The manufacturer should provide adequate laboratory facility to the quality unit. Appropriate microbiological test should be conducted on each batch of intermediate & API where microbial test is required. Impurity profile should be maintained
At regular interval the impurity profile should be challenged against regulatory submission or against historical data. This is required to detect if modification in RM/PM, equipment, operating procedure or the production process.
Exception: Not necessary for herbal/animal tissue origin.

Certificate of analysis:
Quality control should issue certificate of Analysis for an API or Intermediate at the time of releasing the batch. This COA should be shared with customer on request. 
Elements of COA
·        Name of Intermediate or API
·        Batch Number
·        Date of release
·        Expiry Date or Retest date as applicable
·        List of Test performed with acceptance criteria and the result obtained
·        Dated and signed by authorized personnel

·        Name address and telephone number of the original manufacturer

Note: If Analysis is done by repacker or reprocessor, name, address and telephone no. of repacker or reprocessor should be mentioned on COA with the reference to original manufacturer.

            If new certificate are issued by or on behalf of the repacker or reprocessor, agents or brokers, the certificate should mentioned name address and telephone no. of the laboratory that performed the analysis. Reference to the name and address of the original manufacturer and to the original batch certificate copy should be attached.

Validation of Analytical procedure

Analytical method should be validated unless the method used is included in relevant pharmacopeia or other recognized standard reference. The analytical method should be validated on the qualified equipment. However the suitability of all testing method used should be verified under the condition where the method is used and should be documented. In case there is any modification in the validated analytical it should be documented and complete record should be maintained.

Stability Monitoring of APIs

·     Stability Monitoring is required for API.
·     Stability Monitoring is an ongoing testing program to monitor the characteristic of the             API and to confirm appropriate storage condition and retest or expiry dates.
·     The procedure for stability testing should be validated and documented.
·      Stability Sample should be stored in container similar to the market container.
·   The first three commercial batches should be placed for stability to confirm retest and            expiry dates but if the data is available from previous studies that API is stable for at least    two years then fewer batches are acceptable for stability keeping.

Expiry/Retest date
If an intermediate is transferred outside the control of manufacturer’s material management system and an expiry or retest date is assigned can be in form of published data or test result.
The expiry or retest date of the API & intermediate should be based on evaluation of data derived from stability studies. Usually a retest data is used not an expiry date. When the commercial production is not initiated the expiry or retest dates can be based on the pilot scale production if:

·   The method and procedure simulates the final method and procedure of the commercial manufacturing scale.

·    The quality of the final product is equivalent to the material made on the commercial scale

Reserve/Retention sample:

Reserve/Retention sample are one and the same thing. These are kept for potential evaluation of the quality of batches of API. The sample should be kept either one year after the expiry date or for 3 years after the distribution of batches, whichever is longer. Similar packaging system should be used in which the API is dispatched or in packaging system which is more protective. The quantity stored should be equal to at least two full compendial analysis or two full specification analysis (in absence of pharmacopeia monograph)



Qualification: Masters in Industrial Biotechnology Management from Lille Catholic UniveersitySpecialization in QHSE in food and Pharmaceutical Industry.

Next Article Title:  Sampling
   







Any query or suggestions please write your comments at comments section..

www.gmpviolations.com
GMP News, GMP guidelines, GMP Violations, GMP warnings, GMP Trends. A Public Health Global News Portal. (This story has not been edited by GMP Violations staff and is auto-generated from a syndicated feed/ experts experiences sharing.) Disclaimer: The Logos/Images & content posted here are belongs to respective to Authority / owners of firm. The Article posted under public health importance news. Please ensure the guideline as per Regulatory agencies.
Share:

0 comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...

AMAZON BEST DEALS

Popular Posts

AMAZON BEST DEALS

Subscribe Free GMP Guidelines

Enter your email address:

Delivered by FeedBurner

Followers

Printfriendly

Subscribe via email for free

Services

Enter your email address:

Delivered by FeedBurner

Contact Form

Name

Email *

Message *

Menu :
Powered by Blogger.

Visitors

    Translater

    Related Posts Plugin for WordPress, Blogger...

    Category

    2016 (37) 2017 (85) 2018 (9) 211 CFR (1) 211.63 (1) 483 (5) AAFA (1) Abbott (2) AboutUs (1) ALCOA (1) Alerts (2) ANDA (1) Anshu (2) Antibiotics (1) apic (1) APR17 (8) APS (2) Articles (4) AstraZeneca (1) Aug17 (2) Aurobindo (2) Author (2) Authors (8) Biocon (1) cadila (1) capa (3) CDSCO (5) Change control (1) Christian Green (1) cipla (2) Cleaning validation (1) Data Integrity (9) dec16 (15) Definations (1) Deviations (1) Donald Trump’s (2) Downloads (17) Dr.Reddy's (4) eca (1) EIR (1) Eli Lilly (1) ema (12) EU (9) FDA (70) FDA Guide (18) FEB17 (15) Genaral (1) General Health (2) GMP (1) GMP News (36) gsk (2) GuidelineEU (10) GuidelinesG (5) GuidelineW (2) GV/0117/001 (1) GVAuthors (3) Health (4) HOSPIRA (1) ICH (3) ICHGuide (3) import alert (1) India (1) ISPE (1) James Bullock (1) JAN17 (23) Jul17 (8) July17 (1) Jun17 (4) Lupin (2) Mahender (39) MAR17 (13) Mar18 (7) May17 (10) MHRA (3) MHRA guide (1) Mumbai (1) Mylan (4) Natco (1) News (55) Non Complinaces (1) Nov16 (5) Novartis (1) oct (1) Oct16 (10) OCT17 (1) PDA (1) Personnel (1) pfizer (1) pics (8) Picsguide (2) QbD (1) Quality Docs (1) RCA (1) Recall (1) safety (1) Sanjeev Kumar Singh (4) Sanofi (1) Sep16 (6) Siegfried Schmitt (2) SUN (1) TGA (3) TOP 10 PHARMA (1) USP (2) Validation (3) Warning Letters (43) WHO (6) zika (1)

    Sponsors

    Theme Support